ADORA2A and Hypoglycemia: The balanced α2AR-β2AR interaction in WKY may function to prevent excessive norepinephrine release during physiological conditions with increased epinephrine secretion such as hypoglycemia and exercise, since epinephrine is a better agonist for the β2AR subtype than norepinephrine.